X-49219318-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001256789.3(CACNA1F):​c.2673+3G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0552 in 1,205,572 control chromosomes in the GnomAD database, including 1,438 homozygotes. There are 21,173 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.041 ( 84 hom., 1330 hem., cov: 22)
Exomes 𝑓: 0.057 ( 1354 hom. 19843 hem. )

Consequence

CACNA1F
NM_001256789.3 splice_region, intron

Scores

2
Splicing: ADA: 0.0002534
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.999

Publications

4 publications found
Variant links:
Genes affected
CACNA1F (HGNC:1393): (calcium voltage-gated channel subunit alpha1 F) This gene encodes a multipass transmembrane protein that functions as an alpha-1 subunit of the voltage-dependent calcium channel, which mediates the influx of calcium ions into the cell. The encoded protein forms a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. Mutations in this gene can cause X-linked eye disorders, including congenital stationary night blindness type 2A, cone-rod dystropy, and Aland Island eye disease. Alternatively spliced transcript variants encoding multiple isoforms have been observed. [provided by RefSeq, Aug 2013]
CACNA1F Gene-Disease associations (from GenCC):
  • Aland island eye disease
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P
  • CACNA1F-related retinopathy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • congenital stationary night blindness 2A
    Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • X-linked cone-rod dystrophy 3
    Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital stationary night blindness
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant X-49219318-C-T is Benign according to our data. Variant chrX-49219318-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 166778.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0577 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001256789.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1F
NM_001256789.3
MANE Select
c.2673+3G>A
splice_region intron
N/ANP_001243718.1O60840-2
CACNA1F
NM_005183.4
c.2706+3G>A
splice_region intron
N/ANP_005174.2O60840-1
CACNA1F
NM_001256790.3
c.2511+3G>A
splice_region intron
N/ANP_001243719.1O60840-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1F
ENST00000323022.10
TSL:1 MANE Select
c.2673+3G>A
splice_region intron
N/AENSP00000321618.6O60840-2
CACNA1F
ENST00000376265.2
TSL:1
c.2706+3G>A
splice_region intron
N/AENSP00000365441.2O60840-1
CACNA1F
ENST00000376251.5
TSL:1
c.2511+3G>A
splice_region intron
N/AENSP00000365427.1O60840-4

Frequencies

GnomAD3 genomes
AF:
0.0406
AC:
4516
AN:
111126
Hom.:
84
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.00910
Gnomad AMI
AF:
0.0849
Gnomad AMR
AF:
0.0240
Gnomad ASJ
AF:
0.0638
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0212
Gnomad FIN
AF:
0.0809
Gnomad MID
AF:
0.0378
Gnomad NFE
AF:
0.0595
Gnomad OTH
AF:
0.0430
GnomAD2 exomes
AF:
0.0431
AC:
7500
AN:
174086
AF XY:
0.0416
show subpopulations
Gnomad AFR exome
AF:
0.00741
Gnomad AMR exome
AF:
0.0151
Gnomad ASJ exome
AF:
0.0623
Gnomad EAS exome
AF:
0.0000740
Gnomad FIN exome
AF:
0.0857
Gnomad NFE exome
AF:
0.0618
Gnomad OTH exome
AF:
0.0429
GnomAD4 exome
AF:
0.0567
AC:
62073
AN:
1094392
Hom.:
1354
Cov.:
33
AF XY:
0.0550
AC XY:
19843
AN XY:
360494
show subpopulations
African (AFR)
AF:
0.00660
AC:
174
AN:
26355
American (AMR)
AF:
0.0159
AC:
557
AN:
34994
Ashkenazi Jewish (ASJ)
AF:
0.0638
AC:
1234
AN:
19330
East Asian (EAS)
AF:
0.0000995
AC:
3
AN:
30150
South Asian (SAS)
AF:
0.0215
AC:
1151
AN:
53456
European-Finnish (FIN)
AF:
0.0849
AC:
3418
AN:
40248
Middle Eastern (MID)
AF:
0.0308
AC:
108
AN:
3510
European-Non Finnish (NFE)
AF:
0.0632
AC:
53092
AN:
840441
Other (OTH)
AF:
0.0509
AC:
2336
AN:
45908
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
2171
4341
6512
8682
10853
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1976
3952
5928
7904
9880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0406
AC:
4518
AN:
111180
Hom.:
84
Cov.:
22
AF XY:
0.0398
AC XY:
1330
AN XY:
33376
show subpopulations
African (AFR)
AF:
0.00908
AC:
278
AN:
30605
American (AMR)
AF:
0.0240
AC:
251
AN:
10476
Ashkenazi Jewish (ASJ)
AF:
0.0638
AC:
169
AN:
2648
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3516
South Asian (SAS)
AF:
0.0216
AC:
57
AN:
2634
European-Finnish (FIN)
AF:
0.0809
AC:
485
AN:
5995
Middle Eastern (MID)
AF:
0.0461
AC:
10
AN:
217
European-Non Finnish (NFE)
AF:
0.0595
AC:
3147
AN:
52910
Other (OTH)
AF:
0.0424
AC:
64
AN:
1508
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
156
312
467
623
779
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0530
Hom.:
882
Bravo
AF:
0.0358

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
2
not specified (2)
-
-
1
Aland island eye disease (1)
-
-
1
Congenital stationary night blindness 2A (1)
-
-
1
X-linked cone-rod dystrophy 3 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.48
CADD
Benign
17
DANN
Benign
0.60
PhyloP100
1.0
Mutation Taster
=88/12
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00025
dbscSNV1_RF
Benign
0.0060
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41312124; hg19: chrX-49075777; API